STAAR Surgical: Reasonable Risk-Reward For A High-Growth Company

Nov. 28, 2022 5:21 AM ETSTAAR Surgical Company (STAA)26 Comments
Long James profile picture
Long James


  • This company is led by a rockstar CEO that has a proven track record of turning not just STAA but other companies around.
  • Business fundamentals have been improving over the past 7 years across various performance metrics.
  • The company continues to report and expect double-digit revenue growth in its major markets.
  • The valuation is at the lowest it has ever been to be investable for the growth it promises.
Concepts of laser eye surgery or visual acuity check-up

Jun/iStock via Getty Images


Investing in STAAR Surgical (NASDAQ:STAA) is investing in a well-run company led by a great CEO with a proven history of leading companies onto a strong path. STAAR Surgical has a dominant position in its industry. Growth since 2015 has

This article was written by

Long James profile picture
I am a conservative yet opportunistic value investor who have been investing since 2005. I am fact-driven, preferring to let financial data inform me of a company's health, followed by qualitative analysis to fill in the gaps to paint a holistic picture of a company's prospects.I appreciate everyone who reads my research and especially those who drop me questions and comments, and follow me in Seeking Alpha. If you would like to engage in further discussions, you can either message me directly in Seeking Alpha, on Twitter ( or find me on Discord. I am in a discord group led by Motley Fool writer Mr. Eric Cuka.

Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in STAA over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (26)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.